Safety Study of LY3041658 in Healthy Participants

Summary

The main purpose of this study is to evaluate the safety of LY3041658 in healthy participants, including first generation Japanese. The study will also investigate how the drug is processed and affects key immune cells. Study participation will last 4 months. Protocol amended in January, 2016 to include first generation Japanese participants.

Timeline

Start

2014-06-16

Primary completion

2017-02-11

Completion

2017-02-11

Drugs

Indications

No indication recorded.